Yungang Lu - China Biologic Independent Director

Director

Dr. Yungang Lu is Independent Director of China Biologic Products, Inc. Dr. Lu has served as a managing director of Seres Asset Management Limited, an investment manager based in Hong Kong, since August 2009. Dr. Lu also serves as a director of the following listed companies China Techfaith Wireless Communication Technology Ltd., a handheld device company in China, and China Cord Blood Corporationrationration, a provider of cord blood storage services in China. From 2004 to July 2009, Dr. Lu was a Managing Director of APAC Capital Advisors Limited, a Hong Kongbased investment manager specializing in Greater China equities. Dr. Lu was a research analyst with Credit Suisse First Boston, a financial services company, from 1998 to 2004, where his last position was the head of China Research. Before moving to Credit Suisse, he worked as an equity analyst focused on regional infrastructure at JP Morgan Securities Asia, a financial services company, in Hong Kong since 2012.
Age 52
Tenure 12 years
Phone(86) 10 6598 3222
Webwww.chinabiologic.com
Lu received a B.S. in Biology from Peking University, an M.S. in Biochemistry from Brigham Young University and a Ph.D. in Finance from the University of California, Los Angeles.

China Biologic Management Efficiency

The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

Paula MadoffTradeweb Markets
50
Charles SonstebyValvoline
67
Vada ManagerValvoline
59
Mike HusseyTradeweb Markets
46
Robert RowleyTradeweb Markets
66
David NelmsCDW Corp
57
Glenn CreamerCDW Corp
53
Joseph SwedishCDW Corp
66
Gerald EvansValvoline
61
Virginia AddicottCDW Corp
54
Stephen MacadamValvoline
60
Robin SelatiCDW Corp
49
Lynda ClarizioCDW Corp
57
Donna ZarconeCDW Corp
60
Paul FinneganCDW Corp
65
Angela KnightTradeweb Markets
64
Virginia AlbaneseCDW Corp
51
Steven AlesioCDW Corp
64
James JordanTradeweb Markets
47
Carol KruseValvoline
58
Barry AllenCDW Corp
69
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the Peoples Republic of China. China Biologic Products Holdings, Inc. is headquartered in Beijing, the Peoples Republic of China. China Biologic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. China Biologic Products (CBPO) is traded on NASDAQ Exchange in USA and employs 2,246 people.

Management Performance

China Biologic Products Leadership Team

Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Min Fang, Director
Zhijing Liu, Corporate VP
Ming Yang, CFO
Joseph Chow, Independent Director
Gang Yang, Corporate VP and General Manager of Guizhou Taibang
Xiaosheng Shao, Independent Director
Ming Yin, Sr. Corporate VP and Corporate Secretary
Zhijun Tong, Independent Director
Yungang Lu, Independent Director
Wenfang Liu, Independent Director
Wai Yeung, Independent Director
David Li, Director
David Gao, Chairman of the Board and Presidentident, CEO
Xiaoying Gao, Executive Chairman, CEO and Pres

China Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with China Biologic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to EOG Resources could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EOG Resources when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EOG Resources - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EOG Resources to buy it.
The correlation of EOG Resources is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EOG Resources moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EOG Resources moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EOG Resources can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in China Stock

If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.